Macrogenics Inc
(NAS:MGNX)
$
4.36
0.25 (6.07%)
Market Cap: 273.08 Mil
Enterprise Value: 107.83 Mil
PE Ratio: 0
PB Ratio: 2.57
GF Score: 60/100 - Q4 2023 MacroGenics Inc Earnings Call TranscriptMar 07, 2024$20.51 (-4.47%)Earnings
- MacroGenics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 MacroGenics Inc Earnings Call TranscriptNov 06, 2023$5.44 (+2.45%)Earnings
- MacroGenics Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 MacroGenics Inc Earnings Call TranscriptAug 09, 2023$4.98 (+1.84%)Earnings
- Q1 2023 MacroGenics Inc Earnings Call TranscriptMay 09, 2023$7.18 (-0.83%)Earnings
- MacroGenics Inc at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- Q4 2022 MacroGenics Inc Earnings Call TranscriptMar 15, 2023$6.34 (-1.71%)Earnings
- MacroGenics Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- MacroGenics Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 MacroGenics Inc Earnings Call TranscriptNov 03, 2022$4.84 (-0.21%)Earnings
- Zymeworks Inc and MacroGenics Inc at Citi BioPharma Conference - Co Panel: Bispecific Panel TranscriptSep 07, 2022
- Q2 2022 MacroGenics Inc Earnings Call TranscriptAug 08, 2022$4.55 (+3.64%)Earnings
- MacroGenics Inc at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Q1 2022 MacroGenics Inc Earnings Call TranscriptMay 03, 2022$7.75 (+2.11%)Earnings
- MacroGenics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Q4 2021 MacroGenics Inc Earnings Call TranscriptFeb 24, 2022$10.49 (+4.59%)Earnings
- MacroGenics Inc at Citi Immuno-Oncology Summit (Virtual) TranscriptFeb 17, 2022
- MacroGenics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- MacroGenics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Q3 2021 MacroGenics Inc Earnings Call TranscriptNov 02, 2021$20.48 (-1.59%)Earnings
- MacroGenics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- MacroGenics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 MacroGenics Inc Earnings Call TranscriptJul 29, 2021$26.08 (-1.25%)Earnings
- MacroGenics Inc to Discuss the Preliminary MGC018 Results Conference Call TranscriptJun 04, 2021
- Q1 2021 MacroGenics Inc Earnings Call TranscriptApr 29, 2021$35.63 (+0.96%)Earnings
- MacroGenics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Q4 2020 MacroGenics Inc Earnings Call TranscriptFeb 25, 2021$21.88 (+3.84%)Earnings
- MacroGenics Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 24, 2021
- MacroGenics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- MacroGenics Inc to Discuss MARGENZAâ„¢ Approval - Conference Call TranscriptDec 17, 2020
- MacroGenics Inc at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- MacroGenics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2020
- Q3 2020 MacroGenics Inc Earnings Call TranscriptNov 04, 2020$21.06 (+5.25%)Earnings
- MacroGenics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- MacroGenics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 MacroGenics Inc Earnings Call TranscriptJul 30, 2020$26.75 (+3.72%)Earnings
- MacroGenics Inc ASCO 2020 Conference Call TranscriptMay 29, 2020
- Q1 2020 MacroGenics Inc Earnings Call TranscriptMay 05, 2020$7.6 (+6.29%)Earnings
- MacroGenics Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- MacroGenics Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 MacroGenics Inc Earnings Call TranscriptFeb 25, 2020$10.99 (-0.72%)Earnings
- MacroGenics Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- MacroGenics Inc to Review Flotetuzumab Data Presented at the ASH Annual Meeting - Call TranscriptDec 10, 2019
- MacroGenics Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 MacroGenics Inc Earnings Call TranscriptNov 06, 2019$8.37 (-1.53%)Earnings
- MacroGenics Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- MacroGenics Inc at Citi Biotech Conference TranscriptSep 04, 2019
- Q2 2019 MacroGenics Inc Earnings Call TranscriptJul 31, 2019$14.39 (-2.18%)Earnings
- MacroGenics Inc at American Society of Clinical Oncology Conference Call TranscriptJun 04, 2019
- Q1 2019 MacroGenics Inc Earnings Call TranscriptMay 01, 2019$16.78 (+0.06%)Earnings
- Q4 2018 MacroGenics Inc Earnings Call TranscriptFeb 26, 2019$20.84 (-4.10%)Earnings
MacroGenics Inc at JMP Securities Life Sciences Conference Transcript
Jun 16, 2022 / 04:00PM GMT
Release Date Price:
$2.25
(-4.26%)
Silvan Tuerkcan
JMP Securities LLC - Analyst
Thanks. Welcome back. It's my pleasure to host Scott Koenig, CEO of MacroGenics. Thanks for joining us today.
Scott Koenig
MacroGenics, Inc. - President, CEO, & Director
Oh, Silvan, it's a real pleasure. Thank you for the invitation.
Questions & Answers
Silvan Tuerkcan
JMP Securities LLC - Analyst
Yeah, thanks. So maybe I want to start off, just to remind the investors -- they're not as familiar with the story. You have a very broad pipeline. Could you just tell us -- and you have an approved medicine. So maybe you could just briefly tell us about -- quickly -- your pipeline and also what the unique capabilities are of the company in regards to antibody design.
Scott Koenig
MacroGenics, Inc. - President, CEO, & Director
My pleasure. So MacroGenics is a company that's been in existence since 2000 -- over 20 years of operation. We built this company from the ground up as a -- focused on immune-based
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)